Robin Hood Ventures

Robin Hood Ventures is a group of angel investors specializing in early-stage, high-growth companies in the Greater Philadelphia region. They offer capital, mentoring, expertise, and connections to help entrepreneurs build successful businesses. Typically investing between $250k to $500k, Robin Hood collaborates with angels, institutions, and VCs in their network to support companies they understand well. Since 1999, they have invested in over 45 companies across various industries such as software, medical devices, biotech, internet, and financial technology.

Ellen Weber

Executive Director

28 past transactions

Simply Good Jars

Convertible Note in 2020
Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everyday operations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.

ChargeItSpot

Series A in 2016
ChargeItSpot, LLC provides cell phone charging stations and kiosks in the United States and Canada. The company’s cell phone charging stations include touchscreen interface, data tracking and reporting, and promotional features. It operates customizable charging stations in retail stores, malls, casinos, stadiums, hospitals, and arenas, as well as conferences, trade shows, festivals, and special events. The company was founded in 2011 and is based in Philadelphia, Pennsylvania.

Life.io

Seed Round in 2015
Life.io is the world’s first web-based platform specifically designed to help people make better decisions every moment, to take care of themselves more, to engage more, to simply live more. Delivered through insurance companies or employers, it’s always on, sharing inspired ideas on how to live better today and every day after.

Intrommune Therapeutics

Series A in 2019
Intrommune is developing the revolutionary oral mucosal immunotherapy (OMIT) treatment platform for food allergies. OMIT is a long-term, patient-friendly, disease-modifying solution for the 220 million people, including 9 million adults and 6 million children in the U.S., who suffer from life-altering food allergies. Intrommune’s lead product, INT-301, is expected to be a safe, effective and convenient therapy for patients who suffer from peanut allergy. There is no FDA-approved treatment for peanut allergy or any other food allergy.

uTu

Seed Round in 2017
After spending collective decades studying, building, and delivering technologies that connect enterprises to people they arrived at the conclusion that AI powered conversations are going to redefine the relationship between technology and people. They hung a shingle in fall of 2016, got the band back together, and started cranking out some badass code. Their aim is to be part of the vanguard that charts this new world.

Yellowdig

Convertible Note in 2020
Yellowdig's software platform creates a social layer on top of existing enterprise learning systems used by colleges, universities, and organizations. Unlike pre-existing social technology, Yellowdig is designed for higher education institutions. The platform provides instructors and learners with a private and secure experience, controlled and protected within the institution's designated environment. Yellowdig was established in 2015 and is headquartered in Philadelphia, Pennsylvania, USA.

ActiveWorx

Venture Round in 2015
Miria Systems, Inc., is a provider of Digital Business Automation Solutions in the cloud. Miria offers advanced technology solutions built on the IBM DBA Platform, for capture & OCR, AP Automation, Payment Automation & Optimization, and automation of other financial processes. Miria offers additional applications to completely configure the full ActiveOps solution to each unique business. As a subsidiary of OSG Billing, and an IBM Gold Business Partner, Miria enables the digital transformation of business processes through the highest standards of advanced digital business automation technologies.

ReturnLogic

Seed Round in 2020
ReturnLogic is a developer of an automation platform intended to make better marketing decisions and prevent costly product returns. Its platform helps brands give their clients an easy returns process while automating workflows for their customer service and warehouse teams, thereby enabling businesses to optimize their product returns strategy.

ExpressCells

Series A in 2019
ExpressCells is a biotechnology company that uses genetic engineering to create custom cell lines for biological research and drug discovery. The company's primary focus is on creating research tools that will speed drug discovery and provide better disease models for basic researchers. ExpressCells was established by Oscar Perez-Leal and Matt Handel in 2018 and is headquartered in Philadelphia, Pennsylvania.

Preclick

Series A in 2007
Preclick is a media asset management software company founded to provide digital photographers the fastest, easiest and most convenient way to organize, print, preserve and share their digital photos. Preclick builds software for major corporations such as Hewlett-Packard, Wal-Mart, 3M, SanDisk, Costco and many online photofinishers including PhotoWorks, dotPhoto and Adorama. Preclick has collaborated with HP in building HP Photosmart Essential (formerly HP Image Zone Express), the free software that makes it extremely easy to print your photos at home or to effortlessly share them online with your friends and family. The company was founded in 2001 and is headquartered in Atlantic Highlands, New Jersey. As of September 1, 2009, Preclick Corporation operates as a subsidiary of Smilebox, Inc.

Annovis Bio

Series A in 2015
Annovis Bio is specialty pharmaceutical company founded to develop novel treatments for Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative disorders. The company has two compounds in clinical development: Posiphen® targets early stage AD and PD and may stop or slow the progression of the disease; BNC targets late stage AD and may stabilize the decline.

Genome Profiling

Convertible Note in 2020
Genome Profiling, LLC, a bioinformatics company, engages in the discovery of novel epigenetic biomarkers for treating diagnosing, and predicting chronic and life-threatening diseases. It offers GenPro Analytics, a software platform to discover novel epigenetic biomarkers that scientists and medical professionals use to predict, diagnose, and monitor the likelihood and progression of disease in individuals with more sensitivity, specificity, accuracy, and cost-effectiveness. The company was incorporated in 2012 and is based in Wayne, Pennsylvania.

OWIT Global

Series A in 2020
OWIT Global, a provider of global insurance technology, offers solutions to simplify innovation and future-proof insurance processing. It provides discrete and specialized cloud-based microservices to the Global Insurance Industry. Its microservices are designed to operate standalone or to integrate with existing environments. OWIT has developed a library of microservices, which are combined in different configurations, to create targeted solutions. These include Bordereaux Management, Cyber Rating & Distribution, A&H and Specialty Point of Sale, Document Generation, Portal Configuration, including the capability to tailor and build a full suite of PAS microservices. It was founded in 2018 and is headquartered in West Hartford, Connecticut.

OneTwoSee

Venture Round in 2014
OneTwoSee is a Philadelphia-based company that sits at the intersection of digital media, sports and technology. We're on our third-generation of a highly scalable technology platform that delivers real-time sports gamecenters by combining statistics, game data, advanced analytics and social media into a rich, engaging fan experience. Our gamecenters are white labeled and easily integrate into customers' own branded sites and platforms -- be it on browser-based PCs, tablets, smartphones, smart TVs and in-arena displays. Our licensed products -- applications spanning major collegiate and professional sports including baseball, football, basketball, hockey and soccer -- enable anyone with an audience interested in big-time sports to further monetize their audiences with new, high-value ad and sponsorship inventory. Customers easily plug into our managed platform and see immediate ROI. OneTwoSee's customers now include some of the largest names in sports media along with leading companies in the publishing, consumer electronics and enterprise technology sectors.

Life.io

Seed Round in 2016
Life.io is the world’s first web-based platform specifically designed to help people make better decisions every moment, to take care of themselves more, to engage more, to simply live more. Delivered through insurance companies or employers, it’s always on, sharing inspired ideas on how to live better today and every day after.

AlphaPoint

Seed Round in 2014
AlphaPoint is a white-label software company helping make illiquid assets liquid. Through its secure, scalable, and customizable distributed ledger platform, AlphaPoint enables customers to launch and operate new products, markets, and services by providing institutions enterprise-grade Blockchain solutions to digitize assets. The company's mission is to bring asset digitization solutions using Blockchain technologies, integration into the new wave of digital currencies, commodities, and equities. AlphaPoint was founded in 2013 and is headquartered in New York, United States.

Annovis Bio

Post in 2020
Annovis Bio is specialty pharmaceutical company founded to develop novel treatments for Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative disorders. The company has two compounds in clinical development: Posiphen® targets early stage AD and PD and may stop or slow the progression of the disease; BNC targets late stage AD and may stabilize the decline.
Illumina Radiopharmaceuticals

Vuzit

Angel Round in 2008
Vuzit (pronounced views-it) is a Philadelphia-based software company that is addressing the need for a universal, yet enterprise-level, method for sharing, viewing and controlling documents, images and other sensitive content on the web. Organizations are increasingly faced with the technical complexity, legal liabilities and risks associated with sharing documents containing sensitive information online, such as financial records, business contracts, copyrighted material and medical data. Regulatory bodies and organizations are clamoring for better control and monitoring over their valuable information. At the same time, the Internet and the advent of products such as the PDF file, are making document distribution easier, but less secure. The Vuzit family of products addresses these needs, with products built for the small business as well as the multinational giant. The Vuzit DocuPub Platform is a robust, standards-based set of APIs, Web Services and libraries that enable you to embed over 40 different file types in your website or application. The Vuzit Platform contains dozens of features to help control how documents and content are accessed online. Vuzit SecureVu, available mid-2009, allows you superior distribution control over documents in and out of the corporate firewall.

Burrow

Seed Round in 2017
Burrow, Inc. designs, manufactures, and supplies furniture for use in homes. It offers seating products, such as sofas and sectionals, sleepers, loveseats, armchairs, ottomans, and other seating products; tables and rugs; and accessories, including bundles, pillows, throws, sleep kits, and other accessories. The company sells its products through showrooms; and its stores in Washington, Massachusetts, Texas, and California, as well as online. Burrow, Inc. was formerly known as Penn & Hunt, Inc. The company was founded in 2016 and is based in New York, New York. It has a manufacturing facility in Mexico City, Mexico.

Virion Therapeutics

Series A in 2018
Virion Therapeutics, LLC, a biotechnology company, develops immune-based treatments for virally-associated cancers and chronic viral infections. It offers ChiVax and ChiVax-gD vaccines to induce potent and sustained T cell-mediated immune responses against transformed and infected cells. Virion Therapeutics, LLC was incorporated in 2018 and is based in Newark, Delaware.

Novira Therapeutics

Series A in 2013
Novira Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops antiviral drugs for the treatment of chronic hepatitis B infection. It develops core and cccDNA inhibitor anti-HBV drugs. Novira Therapeutics, Inc. was formerly known as Molecmo Nanobiotechnologies, Inc. The company was incorporated in 2006 and is based in Doylestown, Pennsylvania. As of December 4, 2015, Novira Therapeutics, Inc. operates as a subsidiary of Johnson & Johnson.

CloudMine

Series A in 2015
Rethink how you develop mobile applications. Significantly reduce your time to deployment, total cost, and overall ease of mind when it comes to developing mobile applications, integrating disparate datasets and maintaining IT infrastructures. CloudMine is a Managed Mobility solution that: 1) Eliminates the need for ongoing maintenance and management of mobile applications. 2) Accelerates app development by 70% through mobile-optimized infrastructure and a suite of prefabricated web services. 3) Standardizes your mobility platform to provide IT-approved common tooling across all business units.

Annovis Bio

Series A in 2016
Annovis Bio is specialty pharmaceutical company founded to develop novel treatments for Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative disorders. The company has two compounds in clinical development: Posiphen® targets early stage AD and PD and may stop or slow the progression of the disease; BNC targets late stage AD and may stabilize the decline.

FEMSelect

Convertible Note in 2020
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.